Integral Health Asset Management, LLC Halozyme Therapeutics, Inc. Transaction History

Integral Health Asset Management, LLC

  • $850 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$25.81 - $43.62 $4 Million - $6.76 Million
-155,000 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$25.74 - $29.63 $514,799 - $592,600
20,000 Added 14.81%
155,000 $4.07 Million
Q2 2020

Aug 14, 2020
BUY
$16.25 - $26.81 $1.38 Million - $2.28 Million
85,000 Added 170.0%
135,000 $3.62 Million
Q1 2020

May 15, 2020
BUY
$13.9 - $21.83 $695,000 - $1.09 Million
50,000 New
50,000 $900,000

Others Institutions Holding HALO

# of Institutions
543
Shares Held
125M
Call Options Held
294K
Put Options Held
180K
View Full List

About HALOZYME THERAPEUTICS, INC.

HALO Quotes by TradingView
  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Integral Health Asset Management, LLC Portfolio

Follow Integral Health Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email